The global lipase testing market was valued at USD 552.98 Million in 2024, driven by the increasing technical advancements across the globe. The market is anticipated to grow at a CAGR of 6.60% during the forecast period of 2025-2034, with the values likely to reach USD 1047.81 Million by 2034.
Base Year
Historical Year
Forecast Year
The increasing prevalence of pancreatic disorders and chronic diseases globally is driving demand for precise and efficient lipase testing solutions.
Technological advancements in diagnostic tools, such as automated systems and point-of-care kits, are reshaping the market.
Emerging economies with expanding healthcare infrastructures present significant opportunities for market growth through improved accessibility and adoption of advanced testing methods.
Lipase testing measures the level of lipase, an enzyme produced by the pancreas in the blood. Lipase plays a key role in digesting dietary fats by breaking them into smaller components for absorption. Elevated lipase levels often indicate pancreatic conditions, such as pancreatitis, or issues with nearby organs, like the gallbladder or intestines. The test is usually ordered when symptoms like abdominal pain, nausea, or loss of appetite suggest a potential pancreatic problem. Blood is drawn from a vein and analysed in a laboratory. Results help diagnose, monitor, or rule out pancreatic disorders, guiding appropriate treatment plans.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Prevalence Driving Demand for Lipase Testing
The growing prevalence of the disease is a major factor driving market growth for lipase testing. As estimated by the National Cancer Institute, around 66,400 people are expected to be diagnosed with pancreatic cancer, and nearly 51,750 deaths are projected to occur due to the disease in the United States. Along with pancreatic cancer, the rising prevalence of chronic diseases like diabetes, and others are collectively contributing to the market demand for lipase testing, propelling market surge.
Product Launches to Fuel Lipase Testing Market Demand
The market growth is expected to be driven by the introduction of new lipase testing technologies that offer great accuracy, faster turnaround times, and improved diagnostics capabilities. These innovations enhance early detection and treatment of pancreatic disorders, leading to increased adoption across clinical and home settings, further propelling market expansion. For instance, in June 2024, IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, launched the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. The innovative load-and-go workflow of the Catalyst analyzers ensures that tests run effortlessly alongside chemistry profiles, leading to a faster path to diagnosis and enhanced patient outcomes. The Catalyst Pancreatic Lipase Test is projected to be available in the U.S. and Canada by September 2024, with a global rollout to the over 70,000 Catalyst installed base planned to begin in the fourth quarter of 2024.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Lipase Testing Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Kits and Reagents to Dominating the Segment by Type
Kits and reagents hold the largest market share in the global lipase testing market by type, driven by their widespread use in clinical diagnostics and research. Colourimetric and fluorometric reagents, alongside ELISA kits, are favoured for their accuracy, ease of use, and compatibility with automated systems. The rising prevalence of pancreatic disorders and demand for quick, reliable testing solutions further bolster this segment. As diagnostic laboratories expand globally, particularly in emerging economies, the kits and reagents market is poised for robust growth during the forecast period, ensuring consistent market dominance through innovation and increased accessibility.
Lipase Testing Market Segmentation by Technology to Witness Significant Market Growth
ELISA (enzyme-linked immunosorbent assay) is expected to dominate the market by technology due to its high sensitivity, specificity, and scalability in enzyme detection. This technology is extensively used for diagnosing pancreatic conditions, supported by advancements in automated ELISA systems that streamline testing workflows. Increasing adoption in clinical laboratories and the development of novel assay kits further enhance its market presence. The growing focus on early disease detection and personalised medicine ensures that ELISA remains a key driver of market growth, with significant potential for innovation in test development over the forecast period.
Clinical Diagnostics Leading the Segment by Application
Clinical diagnostics will likely hold a substantial share in the global lipase testing market by application, driven by the increasing prevalence of pancreatic and gastrointestinal disorders. Lipase testing is crucial for diagnosing conditions such as pancreatitis and gallbladder diseases, making it indispensable in routine medical practice. The rising awareness of preventive healthcare and advancements in diagnostic technologies strengthen this segment’s market position. As healthcare systems worldwide focus on early detection and management of chronic conditions, clinical diagnostics continues to dominate, with significant growth opportunities fuelled by technological innovation and expanding access to healthcare services.
Lipase Testing Market Share by End User to Undergo Notable Growth
Hospitals and clinics are predicted to hold the largest share of the market by end-user due to their role as primary points of care. These settings are equipped with advanced diagnostic tools and skilled professionals, ensuring accurate and timely results for patients. The growing burden of chronic diseases and increasing patient footfall in hospitals drive demand for lipase testing. Additionally, the expansion of hospital networks, particularly in developing regions, enhances accessibility to these diagnostic services. This segment is poised to sustain its dominance during the forecast period, supported by continuous advancements in healthcare infrastructure.
North America is estimated by the largest share in the market, primarily due to its advanced healthcare infrastructure and strong emphasis on early diagnostics. High prevalence rates of pancreatic disorders, coupled with increasing awareness about preventive healthcare, drive demand for lipase testing. Significant investments in research and development, particularly in the United States, have led to innovative diagnostic solutions and enhanced testing accuracy. Additionally, the region benefits from the widespread adoption of automated technologies and well-established reimbursement policies, making diagnostic services more accessible. With a focus on personalised medicine and ongoing technological advancements, North America is poised to maintain its market leadership during the forecast period.
The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Creative Biomart ] is a leading biotechnology company specialising in providing high-quality proteins, enzymes, and other biological products to researchers and scientists globally. Within its extensive portfolio, Creative Biomart offers a range of lipase testing products, including recombinant lipases, assay kits, and related reagents. These products are designed to support various research applications, including drug discovery, diagnostics, and academic research, ensuring accurate and reliable results in lipase activity measurement.
LifeSpan BioSciences is a prominent provider of antibodies, ELISA kits, and other life science research tools. The company has a comprehensive portfolio for lipase testing, offering a variety of lipase-specific antibodies, ELISA kits, and detection reagents. The company’s products are widely used in clinical research and diagnostics, providing researchers with precise tools to study lipase activity in various biological samples, aiding in the understanding of metabolic disorders and pancreatic function.
Athenese-Dx Private Limited is an innovative diagnostic company focused on developing and manufacturing diagnostic assays and kits. The company’s portfolio includes advanced lipase testing kits that are designed for accurate and rapid diagnosis of conditions such as pancreatitis. Athenese-Dx’s products are known for their ease of use and reliability, making them a preferred choice for clinical laboratories and healthcare providers seeking efficient and dependable diagnostic solutions.
BioAssay Systems is a globally recognised provider of high-quality assay kits for the quantification of bioactive molecules. The company offers a range of lipase assay kits that are used in both research and clinical settings to measure lipase activity in various samples. The company’s lipase testing products are highly valued for their simplicity, accuracy, and compatibility with high-throughput screening methods, making them ideal for large-scale studies and routine diagnostics.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Abbott, Beckman Coulter, Randox Laboratories, DiaSys Diagnostic Systems, DIALAB GmbH, Anamol Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share